244 related articles for article (PubMed ID: 17381636)
21. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
Hauser CJ; Boffard K; Dutton R; Bernard GR; Croce MA; Holcomb JB; Leppaniemi A; Parr M; Vincent JL; Tortella BJ; Dimsits J; Bouillon B;
J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
[TBL] [Abstract][Full Text] [Related]
22. Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage.
Khan AZ; Parry JM; Crowley WF; McAllen K; Davis AT; Bonnell BW; Hoogeboom JE
Am J Surg; 2005 Mar; 189(3):331-4. PubMed ID: 15792762
[TBL] [Abstract][Full Text] [Related]
23. Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center.
Brown CV; Sowery L; Curry E; Valadka AB; Glover CS; Grabarkewitz K; Green T; Hail S; Admire J
Am Surg; 2012 Jan; 78(1):57-60. PubMed ID: 22273315
[TBL] [Abstract][Full Text] [Related]
24. The role of recombinant-activated factor VII in bleeding trauma patients.
Dutton RP; Conti BM
Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
[TBL] [Abstract][Full Text] [Related]
25. Updates in the management of severe coagulopathy in trauma patients.
Lynn M; Jeroukhimov I; Klein Y; Martinowitz U
Intensive Care Med; 2002 Oct; 28 Suppl 2():S241-7. PubMed ID: 12404093
[TBL] [Abstract][Full Text] [Related]
26. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
Caldwell SH; Chang C; Macik BG
Hepatology; 2004 Mar; 39(3):592-8. PubMed ID: 14999675
[TBL] [Abstract][Full Text] [Related]
27. Current world literature. Trauma and transfusion.
Curr Opin Anaesthesiol; 2009 Apr; 22(2):321-5. PubMed ID: 19399963
[No Abstract] [Full Text] [Related]
28. Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma.
Altuncu E; Berrak S; Bilgen H; Yurdakul Z; Canpolat C; Ozek E
J Matern Fetal Neonatal Med; 2007 Aug; 20(8):627-9. PubMed ID: 17674281
[TBL] [Abstract][Full Text] [Related]
29. Management of trauma-induced coagulopathy: trends and practices.
D'Angelo MR; Dutton RP
AANA J; 2010 Feb; 78(1):35-40. PubMed ID: 20977127
[TBL] [Abstract][Full Text] [Related]
30. Near fatal hemorrhage in traumatic bilateral leg amputation with coagulopathy, acidosis, and hypothermia and salvage therapy with recombinant factor VIIa.
Korte WC; Moor S
J Trauma; 2007 Jul; 63(1):E1-4. PubMed ID: 17622857
[No Abstract] [Full Text] [Related]
31. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
32. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
Shamsi T; Tufail M; Aftab M; Ansari S
J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
[TBL] [Abstract][Full Text] [Related]
33. Use of prothrombin complex concentrates in anticoagulation.
van Veen SQ; Strengers PF
Am J Hematol; 2008 Apr; 83(4):344-5. PubMed ID: 18213649
[No Abstract] [Full Text] [Related]
34. Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation.
Kogan A; Berman M; Kassif Y; Raanani E; Stamler A; Ben Gal T; Stein M; Erez E; Vidne BA; Sahar G
J Heart Lung Transplant; 2005 Mar; 24(3):347-9. PubMed ID: 15737765
[TBL] [Abstract][Full Text] [Related]
35. Recombinant factor VIIa and the trauma patient.
Criddle LM
J Emerg Nurs; 2006 Oct; 32(5):404-8. PubMed ID: 16997029
[No Abstract] [Full Text] [Related]
36. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
Lim Y; Loo CC; Chia V; Fun W
Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576
[TBL] [Abstract][Full Text] [Related]
37. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
[TBL] [Abstract][Full Text] [Related]
38. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
Fries D
Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
[TBL] [Abstract][Full Text] [Related]
39. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
40. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
